sophieannasのブログ一覧

Recently, research from the University of Montreal and other agencies developed a diabetes therapy by controlling the patients’ Neu1 level . And the related research performance published in the magazine of《Diabetes》.Portion of insulin resistance in patients with type II diabetes mainly are caused by lacking of certain protein , while this protein has no connection with diabetes . Type II diabetes accounted for 90% of worldwide diabetic population , affecting the health of 2.5 million Canadians , it will takes 15 billion yuan to treat diabetes every year in Canada . The researchers explained that they found Neuraminidase 1 can adjust sialic acid on the surface of cells to realize the opening or closing of body cells absorbing sugar .

Researchers are now trying to look for a method to restore Neu1 level and function . If they can remove sialic acid residues from the surface of cells , they will make the insulin receptor were suitable for carbohydrate absorption. This may give doctors an idea to reduce the use of insulin therapy as well as reduce the prevalence of diabetes.

Usually , diabetes treatment are traditional antibody therapies , this new discovery bring diabetes patients back to life , providing a potential treatment for diabetes . Bioabb is a world famous biotechnology company , focus on high quality antibody production and custom service . Bioabb current antibodies include monoclonal antibodies , polyclonal antibodies , secondary antibodies and others antibodies. Bioabb antibodies are widely used in modern medicine development and clinical disease treatment . Bioabb antibodies are very popular in the antibody market for the high efficiency and good quality . If you want to know more details info about Bioabb antibody , visit http://www.bioabb.com/categories/Antibody/ .